Subject(s)
CD28 Antigens/immunology , CD3 Complex/immunology , Immunotherapy, Adoptive , Interleukin-2/therapeutic use , Lymphocyte Activation/drug effects , Acute Disease , Animals , Cell Line, Tumor , Interleukin-2/administration & dosage , Leukemia, Myeloid/immunology , Leukemia, Myeloid/therapy , Mice , Mice, Transgenic , Neoplasms, Experimental/immunology , Neoplasms, Experimental/therapy , T-Lymphocytes/immunology , T-Lymphocytes/transplantationABSTRACT
The frequency of each B*40 allele was determined by DNA sequencing in four major United States populations: Caucasians, African Americans, Asians/Pacific Islanders, and Hispanics. Thirty-two individuals from each ethnic group, who were previously described serologically as B40, B60, or B61, were randomly selected out of a pool of 82,979 unrelated individuals for allele characterization. Out of nine different B*40 alleles identified in this study, B*4001 and B*4002 were the two most frequent B*40 alleles in all the population groups. B*4001 was the primary B*40 allele seen in Caucasians (83%) and African Americans (76%), while B*4002 was found in the majority of Hispanics (62%). The distributions of both alleles were comparable in the Asian/Pacific Islander population. These two alleles were the only B*40 alleles detected in Caucasians while four to five additional B*40 alleles were seen in the other population groups. The other B*40 alleles detected in this study included: B*4003 and B*4010 in Asian/Pacific Islanders; B*4012 and B*4016 in African Americans; and B*4004, B*4006, and B*4027 in Hispanics. Analysis revealed significant differences between Hispanics and all other groups as well as between African Americans and Asian/Pacific Islanders. This report also describes five novel B*40 alleles: B*4019, B*4020, B*4024, B*4027, and B*4028.
